Literature DB >> 7206062

The value of nuclear bone imaging in advanced prostatic cancer.

J J Pollen, K Gerber, W L Ashburn, J D Schmidt.   

Abstract

The nuclear bone scan is a highly sensitive means of detecting skeletal metastasis in patients with prostatic cancer. Serial bone imaging provides an accurate method to follow the response of osseous metastases to treatment and to detect relapsing disease in the skeleton. In selected instances the nuclear bone scan can provide information about vertebral metastases that can be important for planning palliative treatment of pain.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7206062     DOI: 10.1016/s0022-5347(17)54979-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  [Pharmacological therapy of urogenital cancer: rational routine diagnostic imaging].

Authors:  A Heidenreich; S Krege
Journal:  Urologe A       Date:  2013-11       Impact factor: 0.639

2.  Repeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomy.

Authors:  G M Sundkvist; L Ahlgren; B Lilja; S Mattsson; P A Abrahamsson; L B Wadström
Journal:  Eur J Nucl Med       Date:  1988

3.  [The value of imaging techniques for bone metastases].

Authors:  C Kratochwil
Journal:  Urologe A       Date:  2007-08       Impact factor: 0.639

4.  Bone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancer.

Authors:  Vidija Soerdjbalie-Maikoe; Rob C M Pelger; Guus A B Lycklama à Nijeholt; Jan-Willem Arndt; Aeilko H Zwinderman; Herman Bril; Socrates E Papapoulos; Neveen A T Hamdy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-19       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.